Inductive Bio
Latest round
- Series A
Last raised
- Mar 2025
Total raised
- $29M
Investors
- 8
About Inductive Bio
a. Inductive operates as a provider of molecule compound absorption, distribution, metabolism, excretion, and toxicity or ADMET optimization solutions using machine learning. The company provides a machine learning platform that maps the drivers of small molecule absorption, distribution, metabolism, excretion, and toxicity (ADMET) to optimize initial compounds into leads. The platform also allows scientists to develop candidates faster with better ADMENT properties balance that helps in developing new therapeutics. In May 2025, Inductive Bio, Inc.
Who invested in Inductive Bio
8 investors across 2 rounds
See all investors in Inductive Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Inductive Bio
Who invested in Inductive Bio?
Inductive Bio has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Inductive Bio raised?
Inductive Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Inductive Bio last raise money?
Inductive Bio's most recent round on record is a Series A, in Mar 2025.
What does Inductive Bio do?
Inductive Bio is a biotechnology company.
Where is Inductive Bio headquartered?
Inductive Bio is headquartered in New York, US.
Which VCs invest in companies like Inductive Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Inductive Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Inductive Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.